Standard meta-analysis of 8 trials:
> venMA <-metagen (TE, seTE, studlab,data=Ven,sm="RR", comb.random=F Calculation of meta-regression, all 8 trials Regression over log(mechanical ventilation time)
All 8 trials (the Sadeghpour trial is excluded in this analysis)
> MetaReg <-metareg(venMA,LogVenti) > MetaReg Mixed-Effects Model (k = 8; tau^2 estimator: DL) tau^2 (estimated amount of residual heterogeneity):
0.0017 (SE = 0.0083) tau (square root of estimated tau^2 value):
0.0414 I^2 (residual heterogeneity / unaccounted variability): 11.97% H^2 (unaccounted variability / sampling variability):
1.14 R^2 (amount of heterogeneity accounted for):
96.54%
Test for Residual Heterogeneity: QE(df = 6) = 6.8156, p-val = 0. Thus, the SD for ventilation in the control group was much greater than the SD for each of the other 3 groups.
We were able to contact Dr. Amini and he kindly sent us their data set (email 2018-11-6). We found that there was one patient (#198 male) in the control group who had ventilation time 1333 hours. We removed this outlier and calculated that mean ventilation time 6.68 (SD 4.26) hours in the control group. This revised SD values is closely similar to the SD values of the three other arms, compare above.
We were also able to get more information of the Methods from Dr. Amini (email 2018-12-13), see below.
Risk of bias table

Bias
Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk "Using a computer-based randomization method" (p 130).
Groups were balanced (Table 2) for eg. age, sex, weight, height, baseline diseases, ejection fraction Allocation concealment (selection bias)
Low risk "The patients, the researcher who collected the data and the one who analyzed the data were blinded to the study. However, the physicians and nurses in charge were aware of the allocated groups" (email 2018-12-13).
Blinding of participants and personnel (performance bias)
Given that no benefit was found from vitamin C, we do not consider that this lack of benefit could be biased by "the physicians and nurses in charge were aware of the allocated groups". Therefore we classify this as low risk for personnel.
Blinding of outcome assessment (detection bias)
Given that no benefit was found from vitamin C, we do not consider that this lack of benefit could be biased by "the physicians and nurses in charge were aware of the allocated groups". Therefore we classify this as low risk for outcome assessment. Incomplete outcome data (attrition bias)
Low risk 6 vitamin C participants and 2 control participants discontinued (p 131; Fig 1) and we (HH and EC) removed 1 control participant, see Notes above. Inclusion: >18 yr who were scheduled to undergo CABG.
Exclusion: current AF, temporary or permanent pacemaker, life expectancy <1 month, emergency surgery precluding the initiation of study protocol the evening before surgery, current pregnancy.
Interventions
Vit C before the operation: Dose: 2 g Method: po Timing: "the evening before surgery" Vit C after operation: Dose: 2 g/d "1 gram twice daily" Method: po Duration: 5 d Placebo: "identical placebo capsules at the same intervals"; "the inert substance for both treatment and placebo capsules was talc."
Outcomes
Length of mechanical ventilation
Notes "Both ascorbic acid and inert placebo capsules were prepared by a custom pharmacy" (p 863) indicates that the products were not commercial. Bjorndahl reported the duration of ventilation in vitamin C group as 1.2 (SD 0.8) d and in control group as 1.4 (SD 1.0) d. Calculation of the P-value with the Taylor series formula from these reported mean and SD-values gives P = 0.13. Bjorndahl reported P = 0.032 (Mann Whitney) for the effect of vitamin C on ICU stay. We used this P = 0.032 to calculate the consistent SE(log(RoM), see Supplementary file. 
Risk of bias
Inclusion:
Patients who underwent elective isolated onpump CABG surgery, age >50 yr, no history of CABG surgery, taking beta-blocker before and after surgery.
Exclusion: history of any cardiac arrhythmia and/or being under anti-arrhythmic therapy, being under digoxin therapy, having pacemaker, severe CHF and/or LVEF <30%, renal failure, severe hepatic failure, COPD, no occurrence of intra-or post-operative cardiopulmonary arrest, or any degree of cardiac blockade and/or bradycardia.
Interventions
Vit C before the operation: Dose: 2 g "2 g of vitamin C tablets before the surgery" Method: po Timing: "All patients took the tablets within 12 hours before surgery" (email 2015-9-9) Vit C after operation: Dose: 1 g/d "500 mg twice daily" Method: po Duration: 5 d Placebo: No tablets. The patients received many drugs and it is unlikely that they identified vitamin C among all the other administered drugs. We classify that all the other drugs serve as a functional placebo to vitamin C.
Outcomes
Length of mechanical ventilation
Notes "Our study was funded by Urmia University of Medical Sciences, Iran" (email 2015-10-1).
Additional information was received by emails from Yousef
Rezaei (2015-4-11, 2015-4-22 and 2015-9-9) , see above and below.
Risk of bias table Bias
Authors' judgement Support for judgement
Low risk "All patients were randomized into two groups in a 1:1 ratio using randomnumber table" (p 493).
Groups were balanced (Table 1) for eg. age, sex, smoking, baseline diseases, ejection fraction Allocation concealment (selection bias)
Low risk "Neither ward physician nor Holter interpreter were aware of the patients' group. Only one who analyzed data was aware of the patients' group" (email 2015-4-11) and "we did not let ward physician and surgeons to know which of patients taking vitamin c or not, except for being informed about the conduction of our trial and prescribing some of patients to take vitamin c. Furthermore, patients were informed that they would be included in our trial to be prescribed vitamin c" (email 2015-4-22).
Blinding of participants and personnel (performance bias)
Low risk "Neither ward physician ... were aware of the patients' group. " (email 2015-4-11) and "we did not let ward physician and surgeons to know which of patients taking vitamin c or not, except for being informed about the conduction of our trial and prescribing some of patients to take vitamin c. Furthermore, patients were informed that they would be included in our trial to be prescribed vitamin c" (email 2015-4-22). Blinding of outcome assessment (detection bias)
Low risk
See above.
Incomplete outcome data (attrition bias)
Low risk "There was no patient withdrawal or missing during study. All allocated ones completed study" (email 2015-4-11 and 2015-10-1).
Ebade 2014 Methods
Controlled trial, July 2010 to December 2013 http://www.ejca.eg.net/article.asp?issn=1687-9090;year=2014;volume=8;issue=2;spage=59;epage=65;aulast=Ebade Participants Egypt, CABG patients, 29 M / 11 F; mean age: 55 yr (SD 10 yr); 20 vit C / 20 control.
Inclusion: patients assigned for elective CABG surgery with cardiopulmonary bypass (CPB) were enrolled in the study.
Exclusion: renal or hepatic dysfunction, known hypersensitivity to the studied drugs, COPD, preoperative AF, pacemaker, class I and III antiarrhythmic agents or digoxin, any degree of AV block Interventions Vit C before the operation: Dose: 2 g Method: iv, but not explicitly stated; "after induction of anesthesia" implies iv administration Timing: "after induction of anesthesia" Vit C after operation: Dose: 3 g/d "1 g every 8 h daily until the fifth post-operative day" (p 60). Method: iv, but not explicitly stated. "Control group receiving saline infusion" suggests that vitamin C also was administered by infusion Duration: 5 d Placebo saline infusion
Outcomes
Length of mechanical ventilation
Notes
Very poorly reported study.
We tried to contact Dr. Ebade to ask for the details of their methods (2015-10-30, 2015-11-1, 2015-11-18, 2015-11-23 and 2019-1-9 ), but we did not get any response. Interventions Vit C dosage: Dose: "1.5 gm vitamin C" Method: iv Timing: "every 6 hours" (p 78) Thus, total vitamin C daily dose was 6 g/day. Placebo no explicit placebo. "Control group: 50 septic shock patients received conventional sepsis treatment only" (p 78). The patients received many drugs and it is unlikely that they identified vitamin C among all the other administered drugs. We classify that all the other drugs serve as a functional placebo to vitamin C.
Bias
Outcomes
Length of mechanical ventilation
Notes
Quite poorly reported study.
We tried to contact Dr. Habib to ask for the details of their methods (2019-3-29 and 2019-4-1 and 2019-4-10), but we did not get any response. Quasi-randomization: "All enrolled patients who met the inclusion criteria (n=100) were randomized (even odd randomization technique) into the study" (p 78).
Risk of bias
Groups were balanced (Table 1) for age, sex, APACHE II score, SOFA score, mean arterial pressure, heart rate, respiratory rate, temperature, urine output, (Table 2 ) CRP and procalcitonin Allocation concealment (selection bias)
Unclear risk
Not described
Blinding of participants and personnel (performance bias)
Unclear risk
Not described
Blinding of outcome assessment (detection bias)
Unclear risk
Not described
Incomplete outcome data (attrition bias)
Low risk
The report indicates that 100 participants were enrolled "All enrolled patients who met the inclusion criteria (n=100)", and there are 100 participants in their analysis Sadeghpour 2015 (not included in the statistical models for the 42% dropout rate) Placebo: "The patients in the placebo group received an equal number of identical tablets. The placebo tablets and ampoules were prepared in the same shape and size as the original" (p 2).
Outcomes
Length of mechanical ventilation
Notes
"We paid it by ourselves besides getting help from the Rajaei cardiovascular research center." (email 2015-10-1) Additional information was received by email from Anita Sadeghpour (2015-5-12 and 2015-10-1) , see below and above.
In 2019 we received a response describing that 42% of participants were excluded after randomization. The publication describes 113 vit C / 177 placebo participants which indicates that there is substantial difference in the exclusion rate between the vitamin C and placebo groups. This is such a severe violation of the ITT principle that we exclude the trial from our calculations, but we show the results in Fig. 1 .
Bias
Authors' judgement Support for judgement
Low risk "The study population was randomized one day before surgery to two groups (By using www.randomizer.org) ... The method of randomization was balanced block with an allocation sequence based on a block size of eight" (p 2). However, the sizes of the groups 113 vit C / 177 placebo are not consistent with block randomization. Therefore, we exclude this study in our sensitivity analysis.
Groups were balanced (Table 2) for sex, age, hypertension, diabetes, hyperlipidemia, surgery type were balanced Allocation concealment (selection bias) Low risk "Both the patients and the hospital staff were blind to the treatment allocation" (p 2). Blinding of participants and personnel (performance bias) Low risk "Both the patients and the hospital staff were blind to the treatment allocation" (p 2). "The Vit C was given in the operating room along with the other infusions by anesthesiologist technician" (email 2015-5-12). "The patients in the intervention group received 2 g of vitamin C ... intravenously, immediately before surgery in the operating theatre, followed by 1 g daily oral doses of the tablets for the first four postoperative days. The patients in the placebo group received an equal number of identical tablets. The placebo tablets and ampoules were prepared in the same shape and size as the original ones manufactured by the same pharmaceutical company." (p 2). Blinding of outcome assessment (detection bias)
Low risk
Incomplete outcome data (attrition bias)
High risk "we enrolled 500 patients but we excluded the patients who died on the first postoperative day, those who needed re operation due to technical problems and excessive bleeding, and those who had not received an adequate dose." (email 2019-1-24) . Thus, data is published of 290 participants of 500 enrolled, which means that data of 42% of participants are missing. This is such a severe violation of the ITT principle that we exclude the trial from our nalysis.
Tanaka 2000 Methods
Quasi Quasi-randomization: "Randomization was performed according to the month of admission" (p 327). It is unlikely that randomization of burn patients according to the month of admission causes systematic bias.
Groups were balanced at baseline (Table  1 and Fig 1) for age, sex, weight, kinds of burns, areas of burns, thickness of burns, the number of inhalation injuries, heart rate, mean arterial pressure Allocation concealment (selection bias)
Low risk
Quasi-randomization: "Randomization was performed according to the month of admission" (p 327). It is unlikely that randomization of burn patients according to the month of admission causes systematic bias. There were no baseline difference in age, sex, weight, kinds of burns, areas of burns, thickness of burns, or in the rate of inhalation injuries (Table  1 and Fig 1) . Blinding of participants and personnel (performance bias)
Low risk "The administered volume of ascorbic acid was included in the 24-hour fluid intake calculations" (p 327). This means that patients had same amount of fluids in both groups. In addition, it is highly unlikely that patient with a burn covering greater than 30% TBSA would observe their treatments. Blinding of outcome assessment (detection bias) 
